Difference between revisions of "Alvocidib (Flavopiridol)"
Jump to navigation
Jump to search
m |
m |
||
| Line 14: | Line 14: | ||
[[Category:Orphan drug]] | [[Category:Orphan drug]] | ||
[[Category:Kinase inhibitors]] | [[Category:Kinase inhibitors]] | ||
| − | [[Category: | + | [[Category:CDK inhibitors]] |
[[Category:Acute myeloid leukemia medications]] | [[Category:Acute myeloid leukemia medications]] | ||
Revision as of 23:24, 15 November 2014
Mechanism of action
Flavonoid alkaloid CDK9 kinase inhibitor
Diseases for which it is used
History of changes in FDA indication
- 4/13/2007: Granted orphan status for treatment of B-cell chronic lymphocytic leukemia (B-CLL) or prolymphocytic leukemia arising from CLL.
- 4/23/2014: Granted orphan designation for the treatment of patients with acute myeloid leukemia (AML)